Revolutionizing tuberculosis & pneumonia diagnostics
with breath sampling
The need
-
Global health threat: tuberculosis and pneumonia are the most deadly infectious diseases globally, causing around 4 million deaths annually¹ ​​​
​​
-
Challenge: rapid and accurate identification of the pathogen causing the infection is essential to guide treatment and reduce antibiotic overuse
​​
-
Current limitations: shortcomings of existing sampling methods pose a major barrier to testing. Samples from the lower respiratory tract are hard to obtain, invasive, often unreliable, or prone to errors
​​
-
Innovation needed: experts see breath sampling as a promising, non-invasive solution to transform tuberculosis and pneumonia diagnostics
Our solution: AveloCollect - a breath aerosol collector
-
Our breath sampling kit works with existing molecular tests​
​​
-
Collects disease-causing viruses and bacteria from the lungs for subsequent detection
​​
-
Easy and non-invasive – can be used anywhere, anytime
1. Collect
Breathe for
2 minutes
2. Elute
Transfer to
standard lab tube
3. Test and Treat
Diagnose & treat multiple diseases
The impact
-
Saving lives: better diagnosis for earlier and tailored antibiotic or antiviral treatment​
​​
-
Reducing healthcare costs: easy sample collection and diagnosis to keep patients out of the hospital and lower the annual costs of USD 52 billion in Europe alone²
​​
-
Fighting antimicrobial resistance (AMR): AveloCollect works with existing respiratory multiplex tests which differentiate between viral and bacterial infections to reduce the more than 65% unnecessarily prescribed antibiotics in primary care³
​​
-
Making every breath count: establish breath bioaerosols as a novel sample type for standard clinical diagnosis of respiratory infections
